TB Research

Novel Three-Drug Regimen for Extensively Drug-Resistant Tuberculosis

Richard T. Ellison

Journal watch · 2020-03

Abstract

Current management of extensively drug-resistant tuberculosis (XDR-TB) infections having resistance to agents including isoniazid, rifampin,

MeSH terms

  • Medicine
  • Drug
  • Tuberculosis
  • Regimen
  • Pharmacology
  • Intensive care medicine